Daniel Gold’s Hedge Fund is 3rd in a Week to Buy Arrowhead Research Stock

Daniel Gold, Arrowhead Research: In a filing with the Securities and Exchange Commission, Daniel Gold‘s QVT Financial reported ownership of some 2.05 million shares of Arrowhead Research Corp (NASDAQ:ARWR). The stake represents 5.64% of the company. Arrowhead Research was not mentioned in the QVT’s latest 13F. Last week, Wayne Holman‘s Ridgeback Capital Management and Steven Cohen‘s SAC Capital each reported buying over 5% stakes in the company.


Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!